Cronos: Geographic Expansion Backed By A Strong Balance Sheet

Cronos remains a Strong Buy, supported by robust fundamentals, international expansion, and a depressed $1B valuation with ...

Cronos Group Logs 4Q Loss as Foreign Exchange Losses Drag

Cronos Group swung to a loss in the fourth quarter as foreign exchange losses offset revenue growth. The cannabis company on Thursday posted a net loss of $491,000, or zero cents a share, compared ...

Cronos Group Q4 Earnings Call Highlights

Cronos Group (NASDAQ:CRON) reported what executives described as a record year in 2025, with organic net revenue growth of 25 ...

Cronos swings to Q4 loss as forex transactions weigh on results

Cronos (CRON) stock slides premarket despite Q4 revenue beat and 47% YoY growth as the company swings to a net loss amid forex changes. Read more here.

Cronos Group Inc. (NASDAQ:CRON) Q4 2025 Earnings Call Transcript

Cronos Group Inc. (NASDAQ:CRON) Q4 2025 Earnings Call Transcript February 26, 2026 Cronos Group Inc. beats earnings ...

Cronos Group Inc (CRON) Q4 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ...

Cronos Group Inc (CRON) reports a 47% increase in net revenue and strategic moves in Europe, despite facing regulatory challenges.
CoinJournal

Cronos (CRO) price outlook as Crypto.com secures conditional OCC approval in the US

Crypto.com secures US OCC approval, boosting regulatory credibility and strengthening the long-term case for Cronos (CRO).

Canaccord is bullish on Cronos Group Inc. (CRON)

Cronos Group Inc. (NASDAQ:CRON) is among the 7 Best Cannabis Stocks to Invest In Now. Cronos Group Inc. (NASDAQ:CRON) is among the Best Marijuana Stocks. Canaccord analyst Kenric Tyghe started ...